Course series
Women can lose up to 20% of bone density within five to seven years of menopause — years before routine DXA screening even begins. Learn what to catch, and when.
Course Available from $495
What makes us different
Understand why waiting for DXA screening at 65 can mean missing a decade of preventable bone loss.
Confidently differentiate female pattern hair loss, telogen effluvium, and frontal fibrosing alopecia.
Evaluate the real evidence behind commonly recommended hair and skin products — separate from the marketing.
Apply an equity-centered lens to screening and care across every patient population.
By five to seven years post-menopause, women can lose up to 20% of their bone density — yet DXA screening isn’t recommended until age 65, more than a decade too late. Hair and skin changes tell a similar story: over half of postmenopausal women develop female pattern hair loss, yet it’s rarely discussed in menopause care. Long-Term Implications of Menopause closes both gaps.
You’ll learn the physiology linking estrogen decline to bone loss (osteopenia, osteoporosis, sarcopenia) and to hair and skin changes (female pattern hair loss, telogen effluvium, frontal fibrosing alopecia) — then apply it clinically: interpreting DXA and FRAX® results, evaluating secondary causes of bone loss, and differentiating hair and skin presentations with evidence-based treatment options.
After participating in this activity, learners will be able to:
Overview
Key terms and concepts: osteopenia, osteoporosis, sarcopenia, and the Musculoskeletal Syndrome of Menopause.
Follicle and skin structure changes, and estrogen’s role in collagen, barrier integrity, and vascular regulation.
Identifying patients who warrant evaluation, interpreting DXA and FRAX® results, and ruling out secondary causes of bone loss.
Distinguishing female pattern hair loss, telogen effluvium, and frontal fibrosing alopecia.
Evidence-based pharmacologic and non-pharmacologic strategies for bone health, and an evidence review of commonly recommended hair and skin products.
Initiating patient-centered conversations about bone, hair, and skin changes.
Meet the team
Chief Medical Officer
Dr. Robin Noble moved from general obstetric care into a practice focused entirely on gynecology, fertility, and midlife women’s health, with particular clinical interest in the menopause transition, pelvic pain, and sexual function.
She oversees and guides EncorVita’s clinical strategy and educational content.
Sr. Director of Medical Affairs
Laura Abrignani, NP, MSN, MSCP, brings 30+ years in women’s health and menopause care, plus 17 years leading Medical Affairs at Bayer, Allergan and Conceptus. Harbor-UCLA trained, she joined EncorVita to help close the menopause care gap for women and the providers who serve them.
Medical Writer
Michelle Nezolosky, MPH brings over 10 years of experience in women’s health, clinical research, and medical education. Former Director at HerMD, with research training at Harvard-affiliated Dana-Farber, she combines research expertise and health communications to develop evidence-based education.
In support of improving patient care, this activity has been planned and implemented by EncorVita™ Health and Pinnacle Conference, LLC. Pinnacle Conference, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Any clinician managing midlife patients, especially those fielding questions about bone density, hair thinning, or skin changes that patients often assume are unrelated to menopause.
No. Although we recommend completing the programs in sequence, from Foundations of Menopause to Treatment of Menopause and finally Long-Term Implications of Menopause, we recognize that every learner comes to menopause care with a different level of experience and knowledge base.
If you already have a strong background in menopause care and want to focus on the implications of menopause for long-term health, including areas such as bone, hair, and skin health, you can jump directly into this course.
3 CE credits.
This is an enduring, self-paced online activity. You will have up to 12 months from the date of purchase to complete the course.
No, this course builds your clinical framework for evaluation and conversation; it does not replace diagnostic imaging or specialist referral where indicated.
Yes. A knowledge assessment quiz with a minimum passing score of 80% is required to earn CE credit.
You will have unlimited opportunities to retake the assessment until you achieve a passing score.
Long-Term Implications of Menopause – EncorVita™ Health
Activity Date: August 24, 2026 – August 24, 2029
Activity Type: Enduring
CE: 3 total credits
This activity offers 3 CE credit(s) for:
*All other attendees will receive an AMA PRA Category 1 Credit™ participation certificate
This enduring educational activity consists of self-paced online modules designed to provide healthcare professionals with evidence-based education on the long-term health implications of menopause, with a focus on bone health and menopausal hair and skin changes. Learners will progress through a structured curriculum that combines didactic instruction, interactive knowledge assessments, detailed PDF written material & tables, and clinical case-based learning to strengthen competence in recognizing, evaluating, and managing these common but often underdiagnosed consequences of estrogen deficiency. Content is delivered through recorded educational modules, interactive learning activities, embedded quizzes, and clinical case scenarios. The self-paced format enables learners to complete the curriculum at their convenience while reinforcing knowledge through module-based assessments and clinical application exercises. To claim credit, participants must complete all required educational modules, complete the associated assessments, and submit the post-activity evaluation. Throughout the activity, learners will strengthen their ability to identify patients at risk for long-term complications of menopause, implement timely evidence-based interventions, and provide comprehensive, patient-centered care that promotes healthy aging and improved quality of life.
Approximately 1.3 million women enter menopause each year in the United States, yet many clinicians receive limited formal education on the long-term consequences of estrogen deficiency beyond the management of vasomotor symptoms. Although osteoporosis remains a leading cause of morbidity among postmenopausal women, opportunities for early risk assessment, preventive counseling, and timely intervention are frequently missed. Similarly, menopausal hair and skin changes are often dismissed as normal aging rather than recognized as clinically significant manifestations of hormonal change that can substantially affect quality of life and may benefit from evaluation and treatment. Observable practice gaps include inconsistent osteoporosis risk assessment, underutilization of validated screening tools such as DXA and FRAX, delayed initiation of preventive and therapeutic interventions, limited familiarity with current pharmacologic and nonpharmacologic management strategies, and inadequate evaluation of hair and skin complaints through appropriate history, physical examination, differential diagnosis, and laboratory assessment. These gaps may delay diagnosis, increase fracture risk, and leave patients without appropriate counseling or treatment for symptoms that affect physical and psychosocial well-being.
This activity is suitable for Physicians, Nurses, Pharmacists, Physician Assistants, and other licensed healthcare professionals. It is particularly relevant for physicians, nurse practitioners, physician assistants, registered nurses, pharmacists, and other licensed clinicians practicing in primary care, family medicine, internal medicine, obstetrics and gynecology, endocrinology, women’s health, dermatology, and related specialties who provide care for women during and after the menopause transition.
It is the policy of Pinnacle Conference, LLC, to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. Pinnacle Conference, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Robin Noble, MD, MHCDS, MSCP, has disclosed several financial relationships: Chief Medical Officer, Equity, and Consulting at EncorVita Health; Medical Advisor, Equity, and Consulting at Play Health; Chief Medical Advisor, Equity, and Consulting at Mia Health; Equity and Consultant at Indagare; Chief Medical Advisor at Let’s Talk Menopause; Advisory Board and Equity at Bioceptive; Advisory Board and Equity at GYNtle; Advisory Board and Equity at Immugen; Advisory at DrKumo; Board Member and Shareholder Physician at Intermed, PA.
Laura Abrignani, NP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Isabelle Raymond, PhD, has disclosed several financial relationships: Employee at Nutraceutical Wellness Inc; Advisor and Investor at EncorVita Health.
Corinne Erickson, MD, has disclosed several financial relationships: Speaker at Hydrinity; Speaker at Cartessa; Consultant/Advisor at L’Oreal; Advisor at EncorVita Health.
Chad Schiffman, MHA, has disclosed a financial relationship: Reviewer of course content on behalf of EncorVita Health (via Healthcare Compliance Pros).
Robin Noble, MD, MHCDS, MSCP, has disclosed several financial relationships: Chief Medical Officer, Equity, and Consulting at EncorVita Health; Medical Advisor, Equity, and Consulting at Play Health; Chief Medical Advisor, Equity, and Consulting at Mia Health; Equity and Consultant at Indagare; Chief Medical Advisor at Let’s Talk Menopause; Advisory Board and Equity at Bioceptive; Advisory Board and Equity at GYNtle; Advisory
Board and Equity at Immugen; Advisory at DrKumo; Board Member and Shareholder Physician at Intermed, PA.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Laura Abrignani, NP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Pamela Mehta, MD, has nothing to disclose.
Shafqat Abbas, PharmD, has nothing to disclose.
All relevant financial relationships have been evaluated and mitigated.
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. Pinnacle Conference, LLC, the faculty, planners, and EncorVita™ Health do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
In support of improving patient care, this activity has been planned and implemented by EncorVita™ Health and Pinnacle Conference, LLC. Pinnacle Conference, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Pinnacle Conference, LLC, designates this Enduring activity for a maximum of 3 AMA PRA. Category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 credits™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 credit™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
This activity is designated for 3 contact hours.
To receive CPE credit through CPE Monitor, please ensure you have provided your NABP ePID number and DOB appropriately. If you are unsure or would like to confirm, please contact ce@learnatpinnacle.com within 60 days of completing the activity.
Pinnacle Conference, LLC has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pinnacle Conference, LLC (BOC AP#: JA4008385) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers (ATs). This program is eligible for a maximum of (3) Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (1 IPCE credits = 1 CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (1 hour/60 minutes = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Logs. Performance Indicator selection is at the learner’s discretion.
As a Jointly Accredited Organization, Pinnacle Conference, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 3 General continuing education credits.
Pinnacle Conference, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP. Pinnacle Conference, LLC designates this activity for 3 hours continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
This activity was planned by and for the healthcare team, and learners will receive 3 Interprofessional Continuing Education (IPCE) credits for learning and change.
Enroll now to purchase and get started.
The clinical resources menopause didn’t have – until now
CE Course
CE Course
CE Course
CE Course
No courses match that category yet.
